Upload
others
View
4
Download
0
Embed Size (px)
Citation preview
Manipulation of the immune response
➢ Autoimmune diseases and the pathogenic mechanism
➢ Treatment of unwanted immune responses
Ida Berg – Molecular Immunology – 27.06.2018
Illustration by Julia Yellow via https://www.spectrumnews.org © 2018 Simons Foundation
Ida Berg – Manipulation of the immune response – 26.06.20182
Content
Autoimmune diseases
▪ Self-Tolerance mechanisms
▪ Immune response
▪ Classification
▪ Pathogenic mechanisms of
▪ Systemic Lupus Erythematosus (SLE)
▪ Multiple Sclerosis (MS)
Treatment of unwanted immune response
▪ Conventional drugs
▪ New biologic agents
3
Self-Tolerance Mechanisms
Variety of mechanisms at
different sites and stages of
development
▪ Low level of autoreactivity
is physiologic and crucial to
normal immune function
Ida Berg – Manipulation of the immune response – 26.06.2018
Janeway’s Immunobiology, 2017
4
Central tolerance
▪ Negative selection of
thymocytes in the cortex
or medulla
Ida Berg – Manipulation of the immune response – 26.06.2018
Self-Tolerance
Mechanisms
TCR: T cell receptor
Ja
ne
wa
y’s
Imm
un
ob
iolo
gy,
20
17
5
Self-Tolerance Mechanisms
Elimination of autoreactive B cells in germinal
centers
▪ Hypermutated self-reactive B cell encounters
strong cross-linking of its B-cell receptor
➢ Apoptosis
Ida Berg – Manipulation of the immune response – 26.06.2018
Ja
ne
wa
y’s
Imm
un
ob
iolo
gy,
20
17
6
Development of autoimmune disease
Ida Berg – Manipulation of the immune response – 26.06.2018
Requirements
▪ Triggers often not clear
▪ Ca. 5 % of the population of western countries
are affected
▪ Starts often during adulthood
▪ Many different symptoms that result in tissue
damage
Ja
ne
wa
y’s
Imm
un
ob
iolo
gy,
20
17
Ida Berg – Manipulation of the immune response – 26.06.20187
Classification
Systemic autoimmune diseases
▪ Many tissues are affected
▪ Effector cells target ubiquitous/ abundant autoantigens
▪ Chronical
Organ specific autoimmune diseases
▪ Effector cells target autoantigens restricted to particular
organs
▪ Immune destruction of the target tissue can end
autoimmunity activity
CNS: Central nervous system
8
Classification
→ Occurrence often in clusters
Autoimmune Diseases
Organ Specific
▪ Multiple Sclerosis (MS)
▪ Crohn’s disease
▪ Psoriasis
▪ Type I diabetes mellitus
▪ Vitiligo
▪ Graves’ disease
Systemic
▪ Systemic lupus erythematosus
(SLE)
▪ Rheumatoid arthritis
▪ Scleroderma
▪ Polymyositis
Ida Berg – Manipulation of the immune response – 26.06.2018
Ida Berg – Manipulation of the immune response – 26.06.20189
All aspects of the immune response are involved
Autoantibodies
▪ Anti-receptor AB cause disease by stimulating or blocking receptor function
▪ As immune complexes: complement activation and ligation of Fc receptor cause
inflammation
▪ Antibody-mediated AD can be transferred across placenta to fetus/infant
T cells
▪ Recognize self peptides of self MHC
▪ Local inflammation or direct tissue damage
▪ Help B cells with production of antibodies
B cells
▪ Presenting antigens to stimulate T cells
▪ Secreting pathogenic antibodies
AB: antibody; AD: autoimmune disease
Ida Berg – Manipulation of the immune response – 26.06.201810
Autoantibody-mediated inflammation
Postive feedback loop from inflammation
▪ Early activation phase: few autoantigens
▪ Chronic inflammation leads to tissue damage
▪ Sequestration: exposure of normally “hidden” antigens
▪ Additional autoreactive B cells are recruited
▪ Epitope spreading leads to the targeting of additional antigens
➢ Perpetuation and amplification of disease
11
Autoantibody-mediated inflammation
Ida Berg – Manipulation of the immune response – 26.06.2018
Janeway’s Immunobiology, 2017
12
Classification
→ Occurrence often in clusters
Autoimmune Diseases
Organ Specific
▪ Multiple Sclerosis (MS)
▪ Crohn’s disease
▪ Psoriasis
▪ Type I diabetes mellitus
▪ Vitiligo
▪ Graves’ disease
Systemic
▪ Systemic lupus erythematosus
(SLE)
▪ Rheumatoid arthritis
▪ Scleroderma
▪ Polymyositis
Ida Berg – Manipulation of the immune response – 26.06.2018
13
Systemic Lupus Erythematosus (SLE)
A T-cell-mediated disease
▪ Target: intracellular nucleoprotein antigens (chromatin, spliceosome complex)
Pathophysiology
▪ Systemic inflammation affecting multiple organs (skin, kidney, joints)
▪ Deposition of immune complexes in walls of small blood vessels
• Deposition in renal glomerulus (see below) causes renal failure
Ida Berg – Manipulation of the immune response – 26.06.2018
Ja
ne
wa
y’s
Imm
un
ob
iolo
gy,
20
17
14
SLE
A T-cell-mediated disease
▪ Target: intracellular
nucleoprotein antigens
(chromatin, spliceosome
complex)
Chronic antibody production
▪ Overproduction of
antibody:nucleic acid immune
complexes
▪ Defective clearance of
immune complex
▪ Activation of low-affinity self-
reactive lymphpocytes
Ida Berg – Manipulation of the immune response – 26.06.2018
Janeway’s Immunobiology, 2017
15
Multiple Sclerosis
T-cell-mediated neurologic disease
▪ Target: CNS myelin antigens
▪ Two main phases
• Relapse: symptoms
• Remission: full or partial recovery
• Later progressive phase
Pathophysiology
▪ Lesions in white matter (scars)
▪ Demyelination
▪ Inflammation
▪ Blood-brain barrier disruption
▪ Paralysis
Ida Berg – Manipulation of the immune response – 26.06.2018
16
Multiple Sclerosis
T-cell-mediated neurologic disease
▪ Target: Myelin basic protein, proteolipid protein and myelin oligodendrocyte
glycoprotein
▪ Brain and spinal cord invasion by CD4 T-cells, muscle weakness
Mechanism after blood-brain barrier disruption
▪ Migration of CD4 T-cells out of blood vessels into brain tissue
(Integrin-VCAM interaction)
▪ T cells reencounter their specific antigen presented by MHC II on microglia
▪ Inflammation causes infiltration by TH17 and TH1 effector CD4 T cells and
release of IL-17, INF-γ
Ida Berg – Manipulation of the immune response – 26.06.2018
17
Multiple Sclerosis
Pathogenic mechanism
▪ Different Autoimmune diseases
Ida Berg – Manipulation of the immune response – 26.06.2018
Janeway’s Immunobiology, 2017
18
Treatment of unwanted immune response
Conventional drugs
Ida Berg – Manipulation of the immune response – 26.06.2018
Anti-
inflammatory
Target
▪ Gen
transcription
Cytotoxic
Target
▪ Dividing cells
Immuno-
suppressive
Target
▪ Specific
signaling
pathways
19
Treatment of unwanted immune response
Corticosteroid therapy
▪ Class of Steroid hormones
▪ Corticosteroids have potent broad spectrum of
actions
▪ Also many side-effects
▪ Should be combined with other drugs (cytotoxic
and immunosuppressive)
Ida Berg – Manipulation of the immune response – 26.06.2018
Janeway’s Immunobiology, 2017
20
Treatment of unwanted immune response
New biologic agents
Ida Berg – Manipulation of the immune response – 26.06.2018
Inhibit
lymphocyte
traffic
Target
▪ Integrins
▪ B cells
Block specific
cellular
interaction
Target
▪ T cells
Affect terminal
effector
mechanisms
Target
▪ Cytokines
Monoclonal antibodies Immunomodulatory proteins
21
Treatment of unwanted immune response
Prescription for MS and Crohn’s disease
▪ Endothelium cells express VCAM-1
▪ Effector lymphocytes express α4:β1 integrin
▪ Monoclonal antibody Natalizumab is specific
for α4 subunit
➢ Lymphocytes cannot enter the tissue
Ida Berg – Manipulation of the immune response – 26.06.2018
MS: multiple sclerosis; VCAM: vascular cell adhesion molecules
22
SUMMARY
Autoimmune diseases
▪ Classification: Systemic, Organ-specific
▪ All aspects of the immune response are involved and operate often in parallel
• T cells, B cells, antibodies
Treatment of unwanted immune response
▪ Corticosteroids are anti-inflammatory drugs and normally combined with
cytotoxic or immunosuppressive drugs
▪ Immunomodulatory agents (monoclonal antibodies or fusion proteins) inhibit
the inflammatory actions of TNF-α
Ida Berg – Manipulation of the immune response – 26.06.2018
23
References
▪ Murphy, K., Travers, P., Walport, M., Janeway, C. (2017): Janeway’s
Immunobiology (9th ed.). New York: Garland Science. Pages: 333, 643-669
▪ Steinman, L. (2012): The discovery of natalizumab, a potent therapeutic for
multiple sclerosis. J .Cell Biol. Vol. 199 No.3, 413-416
Ida Berg – Manipulation of the immune response – 26.06.2018
Thank you for your attention!
Any questions?
Illustration by Julia Yellow via https://www.spectrumnews.org © 2018 Simons Foundation